The purpose of this study is to evaluate the performance of the Cardioblate Closure Device to occlude the LAA
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
40
Placement of the occlusion band on the LAA
Eisenhower Medical Center
Rancho Mirage, California, United States
Yale University School of Medicine
New Haven, Connecticut, United States
Northwestern Memorial Hospital
Chicago, Illinois, United States
Oklahoma Heart Hospital
Oklahoma City, Oklahoma, United States
Complete occlusion of the left atrial appendage
Time frame: 3 Months
To evaluate the composite incidence rate of device-related adverse events
Time frame: Discharge/30 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Aurora St. Luke's Medical Center
Milwaukee, Wisconsin, United States